Recurrent Non-small Cell Lung Cancer Terminated Phase 1 Trials for Cisplatin (DB00515)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Terminated1 IdentifierTitlePurposeDrugs
NCT01411098Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryTreatment